MAPT and Alzheimer disease: Taken together, we have found in the present study that downregulation of I2PP2A not only restitutes PP2A activity but also inhibits GSK-3β, which makes I2PP2A a promising target to arrest AD-like tau hyperphosphorylation, and restores dendrite complexity and ameliorates cognitive deficits.